TASER® Conducted electrical weapons: Physiology, pathology, and law

TASER® Conducted Electrical Weapons: Physiology, Pathology, and Law

Volumn , Issue , 2009, Pages 1-457

  Kroll, Mark W ^a   Ho, Jeffrey D ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892137489     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-85475-5     Document Type: Book

References (149)

1. Code 1069 Excited Delirium Dispatch Policy. In: Sheriff's-Office, ed. Jacksonville, FL, 2006.
2. Pollanen MS, Chiasson DA, Cairns JT, Young JG. Unexpected death related to restraint for excited delirium: a retrospective study of deaths in police custody and in the community. CMAJ 1998;158:1603-7.
3. Ruttenber AJ, Lawler-Heavner J, Yin M, Wetli CV, Hearn WL, Mash DC. Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity. J Forensic Sci 1997;42:25-31.
4. Blaho K, Winbery S, Park L, Logan B, Karch SB, Barker LA. Cocaine metabolism in hyperthermic patients with excited delirium. J Clin Forensic Med 2000;7:71-6.
5. Stefan H. Sudden death of psychiatric patients following great excitation and exhaustion which has no actual anatomic basis. Dtsch Med Wehnschr 1934;60:1550-8.
6. Shulack N. Sudden "exhaustive" death in excited patients. Psychiatr Q 1944;18:3-12.
7. Kasantikul D, Kanchanatawan B. Neuroleptic malignant syndrome: a review and report of six cases. J Med Assoc Thai 2006;89:2155-60.
8. Bell L. On a form of disease resembling some advanced stages of mania and fever, but so contradistinguished from any ordinary observed or described combination of symptoms as to render it probable that it may be overlooked and hitherto unrecorded malady. Am J Insanity 1849;6:97-127.
9. Fishbain DA, Wetli CV. Cocaine intoxication, delirium, and death in a body packer. Ann Emerg Med 1981;10:531-2.
10. Karch S, Kroll M. Unpublished observations of 150 excited delirium cases, 2008.
11. Wetli C. Excited delirium. In: Chan R, ed. Sudden Deaths in Custody. Totowa: Humana Press, 2006:99-112.
12. Derby I. Manic-depressive "exhaustion" deaths. Pyschiatric Q 1933;7:436-49.
13. Shulack N. Sudden "exhaustive" death in excited patients. Psychiatr Q 1938;12:282-93.
14. Ross DL. Factors associated with excited delirium deaths in police custody. Mod Pathol 1998;11:1127-37.
15. Stagno D, Gibson C, Breitbart W. The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response. Palliat Support Care 2004;2:171-9.
16. Ross CA, Peyser CE, Shapiro I, Folstein MF. Delirium: phenomenologic and etiologic subtypes. Int Psychogeriatr 1991;3:135-47.
17. Davidson G. Concerning the cause of death in certain cases. Am J Psychiatry 1934;91:41-9.
18. Kraines S. Bell's mania (acute delirium). Am J Psychiatry 1934;91:29-40.
19. Mash DC, Ouyang Q, Pablo J, Basile M, Izenwasser S, Lieberman A, Perrin RJ. Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons. J Neurosci 2003;23:2564-71.
20. Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S. Dopamine transport function is elevated in cocaine users. J Neurochem 2002;81:292-300.
21. Wetli CV, Fishbain DA. Cocaine-induced psychosis and sudden death in recreational cocaine users. J Forensic Sci 1985;30:873-80.
22. Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs 2000;32:137-41.
23. Schroeder U, Schroeder H, Darius J, Grecksch G, Sabel BA. Simulation of psychosis by continuous delivery of phencyclidine from controlled-release polymer implants. Behav Brain Res 1998;97:59-68.
24. Pedal I, Zimmer G, Mattern R, Mittmeyer HJ, Oehmichen M. Fatal incidences during arrest of highly agitated persons. Arch Kriminol 1999;203:1-9.
25. Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am 1997;20:427-51.
26. Di Maio T, VJM D. Excited delirium syndrome cause of death and prevention. Boca Raton: Taylor & Francis, 2006.
27. Stratton SJ, Rogers C, Green K. Sudden death in individuals in hobble restraints during paramedic transport. Ann Emerg Med 1995;25:710-2.
28. Stratton SJ, Rogers C, Brickett K, Gruzinski G. Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med 2001;19:187-91.
29. Park KS, Korn CS, Henderson SO. Agitated delirium and sudden death: two case reports. Prehosp Emerg Care 2001;5:214-6.
30. Swerdlow C, Kroll M, Williams H, Biria M, Lakkireddy D, Tchou P. Presenting rhythm in sudden custodial deaths after use of TASER® electronic control device. Heart Rhythm 2008;5:S44.
31. Nielsen J, Bruhn AM. Atypical neuroleptic malignant syndrome caused by olanzapine. Acta Psychiatr Scand 2005;112:238-40; discussion 240.
32. Ruttenber AJ, McAnally HB, Wetli CV. Cocaine-associated rhabdomyolysis and excited delirium: different stages of the same syndrome. Am J Forensic Med Pathol 1999;20:120-7.
33. Allam S, Noble JS. Cocaine-excited delirium and severe acidosis. Anaesthesia 2001;56:385-6.
34. Brice JH, Pirrallo RG, Racht E, Zachariah BS, Krohmer J. Management of the violent patient. Prehosp Emerg Care 2003;7:48-55.
35. Karch SB. Karch's Pathology of Drug Abuse, CRC Press, Boca Raton, 2002:541.
36. Di Maio VJ. Forensic Pathology, CRC Press, Boca Raton, 2001:656.
37. Gray SD, Fatovich DM, McCoubrie DL, Daly FF. Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust 2007;186:336-9.
38. Morrison A, Sadler D. Death of a psychiatric patient during physical restraint. Excited delirium - a case report. Med Sci Law 2001;41:46-50.
39. Pearlson GD. Psychiatric and medical syndromes associated with phencyclidine (PCP) abuse. Johns Hopkins Med J 1981;148:25-33.
40. Stephens BG, Jentzen JM, Karch S, Mash DC, Wetli CV. Criteria for the interpretation of cocaine levels in human biological samples and their relation to the cause of death. Am J Forensic Med Pathol 2004;25:1-10.
41. Mash DC, Staley JK. D3 dopamine and kappa opioid receptor alterations inhuman brain of cocaine-overdose victims. Ann N Y Acad Sci 1999;877:507-22.
42. Mash DC, Staley JK, Izenwasser S, Basile M, Ruttenber AJ. Serotonin transporters upregulate with chronic cocaine use. J Chem Neuroanat 2000;20:271-80.
43. Stephens BG, Jentzen JM, Karch S, Wetli CV, Mash DC. National Association of Medical Examiners position paper on the certification of cocaine-related deaths. Am J Forensic Med Pathol 2004;25:11-3.
44. Chen L, Segal DM, Moraes CT, Mash DC. Dopamine transporter mRNA in autopsy studies of chronic cocaine users. Brain Res Mol Brain Res 1999;73:181-5.
45. Berankova K, Habrdova V, Balikova M, Strejc P. Methamphetamine in hair and interpretation of forensic findings in a fatal case. Forensic Sci Int 2005;153:93-7.
46. Kimura H, Mukaida M, Mori A. Detection of stimulants in hair by laser microscopy. J Anal Toxicol 1999;23:577-80.
47. Takayama N, Tanaka S, Hayakawa K. Determination of stimulants in a single human hair sample by high-performance liquid chromatographic method with chemiluminescence detection. Biomed Chromatogr 1997;11:25-8.
48. Kintz P, Cirimele V, Tracqui A, Mangin P. Simultaneous determination of amphetamine, methamphetamine, 3, 4-methylenedioxyamphetamine and 3, 4-methylenedioxymethamphetamine in human hair by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl 1995;670:162-6.
49. Nagai T, Kamiyama S, Nagai T. Forensic toxicologic analysis of methamphetamine and amphetamine optical isomers by high performance liquid chromatography. Z Rechtsmed 1988;101:151-9.
50. Sztajnkrycer MD, Baez AA. Cocaine, excited delirium and sudden unexpected death. Emerg Med Serv 2005;34:77-81.
51. O'Halloran RL, Lewman LV. Restraint asphyxiation in excited delirium. Am J Forensic Med Pathol 1993;14:289-95.
52. Strote J, Range Hutson H. Taser use in restraint-related deaths. Prehosp Emerg Care 2006;10:447-50.
53. Paquette M. Excited delirium: does it exist? Perspect Psychiatr Care 2003;39:93-4.
54. Gowers WR. A Manual of Diseases of the Nervous System, J&A Churchill, London, 1896.
55. Nahas GG, Burks TF, Hollister LE. Drug Abuse in the Decade of the Brain, IOS Press, Amsterdam, 1997:281.
56. Levine B. Principles of Forensic Toxicology, AACC, Washington, DC, 2003:385.
57. Karch SB. Drug Abuse Handbook, CRC Press, Boca Raton, FL, 2006:1267.
58. Mets B, Jamdar S, Landry D. The role of catecholamines in cocaine toxicity: a model for cocaine "sudden death". Life Sci 1996;59:2021-31.
59. Karch SB, Wetli CV. Agitated delirium versus positional asphyxia. Ann Emerg Med 1995;26:760-1.
60. Wetli CV, Mash D, Karch SB. Cocaine-associated agitated delirium and the neuroleptic malignant syndrome. Am J Emerg Med 1996;14:425-8.
61. Mirchandani HG, Rorke LB, Sekula-Perlman A, Hood IC. Cocaine-induced agitated delirium, forceful struggle, and minor head injury. A further definition of sudden death during restraint. Am J Forensic Med Pathol 1994;15:95-9.
62. Irwin P, Murray S, Bilinski A, Chern B, Stafford B. Alcohol withdrawal as an underrated cause of agitated delirium and terminal restlessness in patients with advanced malignancy. J Pain Symptom Manage 2005;29:104-8.
63. Morita T, Tei Y, Inoue S. Agitated terminal delirium and association with partial opioid substitution and hydration. J Palliat Med 2003;6:557-63.
64. Morita T, Tei Y, Inoue S. Impaired communication capacity and agitated delirium in the final week of terminally ill cancer patients: prevalence and identification of research focus. J Pain Symptom Manage 2003;26:827-34.
65. Vatsavayi V, Malhotra S, Franco K. Agitated delirium with posterior cerebral artery infarction. J Emerg Med 2003;24:263-6.
66. Vilke GM, Chan TC. Agitated delirium and sudden death. Prehosp Emerg Care 2002;6:259; author reply 259-60.
67. Frye MA, Coudreaut MF, Hakeman SM, Shah BG, Strouse TB, Skotzko CE. Continuous droperidol infusion for management of agitated delirium in an intensive care unit. Psychosomatics 1995;36:301-5.
68. Levenson JL. High-dose intravenous haloperidol for agitated delirium following lung transplantation. Psychosomatics 1995;36:66-8.
69. Sanders KM, Murray GB, Cassem NH. High-dose intravenous haloperidol for agitated delirium in a cardiac patient on intra-aortic balloon pump. J Clin Psychopharmacol 1991;11:146-7.
70. Verslegers W, De Deyn PP, Saerens J, Marien P, Appel B, Pickut BA, Lowenthal A. Slow progressive bilateral posterior artery infarction presenting as agitated delirium, complicated with Anton's syndrome. Eur Neurol 1991;31:216-9.
71. Mori E, Yamadori A. Acute confusional state and acute agitated delirium. Occurrence after infarction in the right middle cerebral artery territory. Arch Neurol 1987;44:1139-43.
72. Julien J, Vital C, Vallat JM, Bourgoin B. Epilepsy and agitated delirium caused by an astrocytoma of the amygdala. Eur Neurol 1979;18:387-90.
73. Medina JL, Chokroverty S, Rubino FA. Syndrome of agitated delirium and visual impairment: a manifestation of medial temporo-occipital infarction. J Neurol Neurosurg Psychiatry 1977;40:861-4.
74. Medina JL, Rubino FA, Ross E. Agitated delirium caused by infarctions of the hippocampal formation and fusiform and lingual gyri: a case report. Neurology 1974;24:1181-3.
75. Horenstein S, Chamberlin W, Conomy J. Infarction of the fusiform and calcarine regions: agitated delirium and hemianopia. Trans Am Neurol Assoc 1967;92:85-9.
76. Spiller JA, Keen JC. Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care. Palliat Med 2006;20:17-23.
77. Pruett JR, Rizvi ST. A16-year-old girl with excited catatonia treated with low-dose oral Lorazepam. J Child Adolesc Psychopharmacol 2005;15:1005-10.
78. Kusne S, Smilack J. Transmission of rabies virus from an organ donor to four transplant recipients. Liver Transpl 2005;11:1295-7.
79. Duggal MK, Singh A, Arunabh, Lolis JD, Guzik HJ. Olanzapine-induced vasculitis. Am J Geriatr Pharmacother 2005;3:21-4.
80. Ogasawara K, Komoribayashi N, Kobayashi M, Fukuda T, Inoue T, Yamadate K, Ogawa A. Neural damage caused by cerebral hyperperfusion after arterial bypass surgery in a patient with moyamoya disease: case report. Neurosurgery 2005;56:E1380; discussion E1380.
81. Srinivasan A, Burton EC, Kuehnert MJ, Rupprecht C, Sutker WL, Ksiazek TG, Paddock CD, Guarner J, Shieh WJ, Goldsmith C, Hanlon CA, Zoretic J, Fischbach B, Niezgoda M, El-Feky WH, Orciari L, Sanchez EQ, Likos A, Klintmalm GB, Cardo D, Le Duc J, Chamberland ME, Jernigan DB, Zaki SR. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005;352:1103-11.
82. Cameron D, Bridge D, Blitz-Lindeque J. Use of sedation to relieve refractory symptoms in dying patients. S Afr Med J 2004;94:445-9.
83. Muller-Busch HC, Andres I, Jehser T. Sedation in palliative care - a critical analysis of 7 years experience. BMC Palliat Care 2003;2:2.
84. Cowan JD, Palmer TW. Practical guide to palliative sedation. Curr Oncol Rep 2002;4:242-9.
85. Cheng C, Roemer-Becuwe C, Pereira J. When midazolam fails. J Pain Symptom Manage 2002;23:256-65.
86. Morita T, Tsunoda J, Inoue S, Chihara S. Terminal sedation for existential distress. Am J Hosp Palliat Care 2000;17:189-95.
87. Travis SS, Conway J, Daly M, Larsen P. Terminal restlessness in the nursing facility: assessment, palliation, and symptom management. Geriatr Nurs 2001;22:308-12.
88. Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001;21:467-72.
89. Ogasawara K, Ogawa A, Okuguchi T, Kobayashi M, Suzuki M, Yoshimoto T. Postoperative hyperperfusion syndrome in elderly patients with chronic subdural hematoma. Surg Neurol 2000;54:155-9.
90. Dunlop RJ, Campbell CW. Cytokines and advanced cancer. J Pain Symptom Manage 2000;20:214-32.
91. Wein S. Sedation in the imminently dying patient. Oncology (Williston Park) 2000;14:585-92; discussion 592, 597-8, 601.
92. Fainsinger RL, Bruera E. When to treat dehydration in a terminally ill patient? Support Care Cancer 1997;5:205-11.
93. Black KJ, Perlmutter JS. Septuagenarian Sydenham's with secondary hypomania. Neuropsychiatry Neuropsychol Behav Neurol 1997;10:147-50.
94. Vaphiades MS, Celesia GG, Brigell MG. Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways. Neurology 1996;47:408-17.
95. Moyle J. The use of propofol in palliative medicine. J Pain Symptom Manage 1995;10:643-6.
96. Di Salvo TG, O'Gara PT. Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients. Clin Cardiol 1995;18:285-90.
97. Nicolai A, Lazzarino LG. Acute confusional states secondary to infarctions in the territory of the posterior cerebral artery in elderly patients. Ital J Neurol Sci 1994;15:91-6.
98. Sanders KM, Stern TA. Management of delirium associated with use of the intra-aortic balloon pump. Am J Crit Care 1993;2:371-7.
99. Fernandez F, Holmes VF, Adams F, Kavanaugh JJ. Treatment of severe, refractory agitation with a haloperidol drip. J Clin Psychiatry 1988;49:239-41.
100. Swedlow DB, Schreiner MS. Management of Reye's syndrome. Crit Care Clin 1985;1:285-311.
101. Price J, Whitlock FA, Hall RT. The psychiatry of vertebro-basilar insufficiency with the report of a case. Psychiatr Clin (Basel) 1983;16:26-44.
102. Steinhart MJ. Treatment of delirium - a reappraisal. Int J Psychiatry Med 1978;9:191-7.
103. Brenner WI, Lieberman AN. Acute clonidine withdrawal syndrome following openheart operation. Ann Thorac Surg 1977;24:80-2.
104. Wendkos M. Acute Exhaustive Mania Sudden Death and Psychiatric Illness. New York: Medical & Scientific Books division of Spectrum Publications, 1979: Chapter 10.
105. Mann SC, Caroff SN, Bleier HR, Welz WK, Kling MA, Hayashida M. Lethal catatonia. Am J Psychiatry 1986;143:1374-81.
106. Ho JD, Dawes DM, Reardon RF, Lapine AL, Dolan BJ, Lundin EJ, Miner JR. Echocardiographic evaluation of a TASER-X26 application in the ideal human cardiac axis. Acad Emerg Med 2008.
107. Dawes D, Ho J, Miner J. Echocardiographic evaluation of TASER X26® probe deployment into the chest of human volunteers. Australas Coll Emerg Med Sci Assem 2008.
108. Dawes D, Ho J, Miner J. The neuroendocrine effects of the TASER X26: A brief report. Forensic Sci Int 2009: in press.
109. Vilke GM, Sloane C, Levine S, Neuman T, Castillo E, Chan TC. Twelve-lead electrocardiogram monitoring of subjects before and after voluntary exposure to the Taser X26. Am J Emerg Med 2008;26:1-4.
110. Sloane CM, Chan TC, Levine SD, Dunford JV, Neuman T, Vilke GM. Serum troponin I measurement of subjects exposed to the Taser X-26. J Emerg Med 2008;35:29-32.
111. Ho JD, Dawes DM, Bultman LL, Moscati RM, Janchar J, Miner JR. Prolonged TASER® use on exhausted humans does not worsen markers of acidosis. Am J Emerg Med 2008: in press.
112. Ho J, Lapine A, Joing S, Reardon R, Dawes D. Confirmation of respiration during trapezial conducted electrical weapon application. Acad Emerg Med 2008;15:398.
113. Ho J, Dawes D. The effect of the extended range electronic projectile (XREP) on breathing. Australian College of Emergency Medicine Winter Symposium. Newcastle, NSW, 2008.
114. Dawes DM, Ho JD, Johnson MA, Lundin E, Janchar TA, Miner JR. 15-Second conducted electrical weapon exposure does not cause core temperature elevation in nonenvironmentally stressed resting adults. Forensic Sci Int 2008;176:253-7.
115. Vilke GM, Sloane CM, Bouton KD, Kolkhorst FW, Levine SD, Neuman TS, Castillo EM, Chan TC Physiological effects of a conducted electrical weapon on human subjects. Ann Emerg Med 2007;50:569-75.
116. Vilke G, Sloane C, Levine S, Neuman T, Castillo E, Chan T. Does the Taser cause electrical changes in twelve lead ECG monitoring of human subjects. J Acad Emerg Med 2007; Abstracts: 257.
117. Vilke G, Sloane C, Bouton K, Levine S, Neuman T, Castillo E, Kolkhorst F, Chan T. Cardiovascular and metabolic effects of the TASER on human subjects. J Acad Emerg Med 2007;14:104.
118. Moscati R, Ho J, Dawes D, Miner J, Reardon R, Heegaard W, Janchar T, Johnson M, Bultman L. Physiologic effects of prolonged conducted electrical weapon discharge on intoxicated adults. Soc Acad Emerg Med abstract issue 2007.
119. Levine SD, Sloane CM, Chan TC, Dunford JV, Vilke GM. Cardiac monitoring of human subjects exposed to the taser. J Emerg Med 2007;33:113-7.
120. Chan T, Sloane C, Neuman T, Levine S, Castillo E, Vilke G, Bouton K, Kohokorst F. The impact of the Taser weapon on respiratory and ventilatory function in human subjects. Acad Emerg Med 2007;14:191-192.
121. ® electrical conducted energy weapons (CEWs) Ann Emerg Med2007;50:S65.
122. Eastman AL, Metzger JC, Pepe PE, Benitez FL, Decker J, Rinnert KJ, Field CA, Friese RS. Conductive electrical devices: a prospective, population-based study of the medical safety of law enforcement use. J Trauma 2008;64:1567-72.
123. Ideker RE, Dosdall DJ. Can the direct cardiac effects of the electric pulses generated by the TASER X26 cause immediate or delayed sudden cardiac arrest in normal adults? Am J Forensic Med Pathol 2007;28:195-201.
124. Lakkireddy D, Wallick D, Verma A, Ryschon K, Kowalewski W, Wazni O, Butany J, Martin D, Tchou PJ. Cardiac effects of electrical stun guns: does position of barbs contact make a difference? Pacing Clin Electrophysiol 2008;31:398-408.
125. Valentino DJ, Walter RJ, Dennis AJ, Nagy K, Loor MM, Winners J, Bokhari F, Wiley D, Merchant A, Joseph K, Roberts R. Acute effects of MK63 stun device discharges in miniature swine. Mil Med 2008;173:167-73.
126. Nanthakumar K, Billingsley IM, Masse S, Dorian P, Cameron D, Chauhan VS, Downar E, Sevaptsidis E. Cardiac electrophysiological consequences of neuromuscular incapacitating device discharges. J Am Coll Cardiol 2006;48:798-804.
127. Biegelmeier G. Effect of current passing through the human body and the electrical impedance of the human body: A guide to IEC-Report 469. VDE, -Verlag, Berlin: ETZ, 1987.
128. Biegelmeier G, Lee WR. New considerations on the threshold of ventricular fibrillation for a.c.shocks at 50-60 Hz. IEEProc. 1980;127:Pt. A: 103-110.
129. Sharma AD, Fain E, O'Neill PG, Skadsen A, Damle R, Baker J, Chauhan V, Mazuz M, Ross T, Zhang Z. Shock on T versus direct current voltage for induction of ventricular fibrillation: a randomized prospective comparison. Pacing Clin Electrophysiol 2004;27:89-94.
130. Weismuller P, Richter P, Binner L, Grossmann G, Hemmer W, Hoher M, Kochs M, Hombach V. Direct current application: easy induction of ventricular fibrillation for the determination of the defibrillation threshold in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1992;15:1137-43.
131. Frame R, Brodman R, Furman S, Kim SG, Rot J, Ferrick K, Hollinger I, Gross J, Fisher JD. Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold testing. Pacing Clin Electrophysiol 1992;15:870-7.
132. Schipke JD, Heusch G, Sanii AP, Gams E, Winter J. Static filling pressure in patients during induced ventricular fibrillation. Am J Physiol Heart Circ Physiol 2003;285:H2510-5.
133. Frame R, Brodman R, Furman S, Kim SG, Roth J, Ferrick K, Hollinger I, Gross J, Fisher JD. Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold testing. Pacing Clin Electrophysiol 1992;15:870-7.
134. Stratton SJ, Rogers C, Brickett K, Gruzinski G. Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med 2001;19:187-91.
135. Park KS, Korn CS, Henderson SO. Agitated delirium and sudden death: two case reports. Prehosp Emerg Care 2001;5:214-6.
136. Di Maio T, VJM D. Excited Delirium Syndrome Cause of Death and Prevention. Boca Raton: Taylor & Francis, 2006.
137. Swerdlow C, Kroll M, Williams H, Biria M, Lakkireddy D, Tchou P. Presenting rhythm in sudden custodial deaths after use of TASER® electronic control device. Heart Rhythm 2008;5:S44.
138. Allison JS, Qin H, Dosdall DJ, Huang J, Newton JC, Allred JD, Smith WM, Ideker RE. The transmural activation sequence in porcine and canine left ventricle is markedly different during long-duration ventricular fibrillation. J Cardiovasc Electrophysiol 2007;18:1306-12.
139. Veltmann C, Borggrefe M, Schimpf R, Wolpert C. Fatal inappropriate ICD shock. J Cardiovasc Electrophysiol 2007;18:326-8.
140. Wu J, Sun H, O'Rourke A, Huebner S, Rahko P, Will J, Webster J. Taser blunt dart-toheart distance causing ventricular fibrillation in pigs. IEEE Trans Biomed Eng 2009: in press.
141. Walter RJ, Dennis AJ, Valentino DJ, Margeta B, Nagy KK, Bokhari F, Wiley DE, Joseph KT, Roberts RR. TASER X26 discharges in swine produce potentially fatal ventricular arrhythmias. Acad Emerg Med 2008;15:66-73.
142. Wu J, Sun H, O'Rourke A, Huebner S, Rahko P, Will J, Webster J. Taser dart-to-heart distance that causes ventricular fibrillationin pigs. IEEE Trans Biomed Eng, 2007;54:503-8.
143. Dalziel CF, Lee WR. Reevaluation of lethal electric currents. IEEE Trans Ind Gen Appl 1968; IGA-4:467-6.
144. Kroll MW, Calkins H, Luceri RM, Graham M, Heegaard W. Sensitive swine and TASER electronic control devices. Acad Emerg Med 2008;15:695-6.
145. Pak HN, Kim YH, Lim HE, Chou CC, Miyauchi Y, Fang YH, Sun K, Hwang C, Chen PS. Role of the posterior papillary muscle and purkinje potentials in the mechanism of ventricular fibrillation in open chest dogs and swine: effects of catheter ablation. J Cardiovasc Electrophysiol 2006;17:777-83.
146. Cao M, Shinbane JS, Gillberg JM, Saxon LA. Taser-induced rapid ventricular myocardial capture demonstrated by pacemaker intracardiac electrograms. J Cardiovasc Electrophysiol 2007;18:876-9.
147. Kroll M, Luceri RM, Calkins H. A very interesting case study involving a TASER conducted electrical weapon (CEW) used on a patient with a pacemaker. J Cardiovasc Electrophysiol 2007;18:E29-30; author reply E31.
148. Kim PJ, Franklin WH. Ventricular fibrillation after stun-gun discharge. N Engl J Med 2005;353:958-9.
149. Swerdlow CD, Olson WH, O'Connor ME, Gallik DM, Malkin RA, Laks M. Cardiovascular collapse caused by electrocardiographically silent 60-Hz intracardiac leakage current. Implications for electrical safety. Circulation 1999;99:2559-64.